|
|
||||||||
American Journal of Clinical Nutrition, Vol 51, 859-863, Copyright © 1990 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
BS Das, DI Thurnham, JK Patnaik, DB Das, R Satpathy and TK Bose
Department of Biochemistry, Ispat General Hospital, Orissa, India.
Plasma lipid peroxides were measured as malonyldialdehyde (MDA) by the thiobarbituric acid (TBA) method in 75 children suffering from Plasmodium falciparum malaria. Their riboflavin status was assessed by measuring erythrocyte glutathione reductase activation coefficients (EGRACs), and values greater than 1.40 were regarded as indicating biochemical deficiency. Plasma MDA was higher (p less than 0.001) in patients than in control subjects; the concentrations were 3.65 +/- 0.70 and 1.77 +/- 0.45 mumol/L (means +/- SD), respectively. The riboflavin-deficient group had higher plasma MDA values (3.98 +/- 0.70 mumol/L) than did the nondeficient group (3.30 +/- 0.68 mumol/L, p less than 0.001). Plasma MDA concentrations correlated with EGRACs (r = 0.46, p less than 0.01) in the patients. It is proposed that riboflavin deficiency restricts regeneration of reduced glutathione making the parasitized erythrocytes more vulnerable to destructive lipid peroxidation and increasing plasma lipid hydroperoxides.
This article has been cited by other articles:
![]() |
F. TRAUNMULLER, M. RAMHARTER, H. LAGLER, F. THALHAMMER, P. G. KREMSNER, W. GRANINGER, and S. WINKLER NORMAL RIBOFLAVIN STATUS IN MALARIA PATIENTS IN GABON Am J Trop Med Hyg, February 1, 2003; 68(2): 182 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Akompong, N. Ghori, and K. Haldar In Vitro Activity of Riboflavin against the Human Malaria Parasite Plasmodium falciparum Antimicrob. Agents Chemother., January 1, 2000; 44(1): 88 - 96. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |